Molecular Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nuttall, R. K.
Right arrow Articles by Edwards, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nuttall, R. K.
Right arrow Articles by Edwards, D. R.
Molecular Cancer Research 1:333-345 (2003)
© 2003 American Association for Cancer Research


Angiogenesis, Metastasis, and the Cellular Microenvironment

Elevated Membrane-Type Matrix Metalloproteinases in Gliomas Revealed by Profiling Proteases and Inhibitors in Human Cancer Cells1

Robert K. Nuttall1, Caroline J. Pennington1, Jennifer Taplin1, Alison Wheal1, Voon Wee Yong2,3, Peter A. Forsyth2,3,4 and Dylan R. Edwards1

1 School of Biological Sciences, University of East Anglia, Norwich, Norfolk, United Kingdom;
2 Departments of Oncology and 3 Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada; and
4 Tom Baker Cancer Centre, Alberta, Canada

Requests for reprints: Dylan Edwards, School of Biological Sciences, University of East Anglia, Norwich, Norfolk NR4 7TJ, United Kingdom. Phone: 44-1603-592184; Fax: 44-1603-592250. E-mail: dylan.edwards{at}uea.ac.uk

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) regulate proteolysis of the extracellular matrix and other extracellular proteins, including growth factors and their receptors. The aberrant expression of these genes is common in most cancers. We profiled the RNA levels of every human MMP and TIMP in a variety of cell types (fibroblast, endothelial, hematopoietic, carcinoma, melanoma, and glioma) using quantitative PCR, with the aim of identifying novel expression patterns. Almost all members of the membrane-type (MT-) MMP and TIMP families were elevated in glioma lines compared to carcinomas. In clinical glioma specimens, there were positive correlations between glioma grade and RNA levels of MT-1, MT-2, and MT-6 MMP, TIMP-1 and TIMP-2, and for several growth factors and receptors. These findings suggest that advanced malignant gliomas have elevated levels of membrane-associated MMPs and TIMPs, which may potentially regulate vascularization and invasion. Concurrent elevation of signaling molecules suggests potential bidirectional relationships that enhance tumor aggressiveness.




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
G. S. Butler, R. A. Dean, E. M. Tam, and C. M. Overall
Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding
Mol. Cell. Biol., August 1, 2008; 28(15): 4896 - 4914.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
B. Annabi, S. Rojas-Sutterlin, C. Laflamme, M.-P. Lachambre, Y. Rolland, H. Sartelet, and R. Beliveau
Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive Phenotype
Mol. Cancer Res., June 1, 2008; 6(6): 907 - 916.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Partridge, M. A. Madsen, V. C. Ardi, T. Papagiannakopoulos, T. A. Kupriyanova, J. P. Quigley, and E. I. Deryugina
Functional Analysis of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases Differentially Expressed by Variants of Human HT-1080 Fibrosarcoma Exhibiting High and Low Levels of Intravasation and Metastasis
J. Biol. Chem., December 7, 2007; 282(49): 35964 - 35977.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. M. Hodgkinson, G. Duncan, L. Wang, C. J. Pennington, D. R. Edwards, and I. M. Wormstone
MMP and TIMP Expression in Quiescent, Dividing, and Differentiating Human Lens Cells
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4192 - 4199.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Sun, C. R. Weber, A. Sohail, M. M. Bernardo, M. Toth, H. Zhao, J. R. Turner, and R. Fridman
MMP25 (MT6-MMP) Is Highly Expressed in Human Colon Cancer, Promotes Tumor Growth, and Exhibits Unique Biochemical Properties
J. Biol. Chem., July 27, 2007; 282(30): 21998 - 22010.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Harris, R. K. Nuttall, P. T. Elkington, J. A. Green, D. E. Horncastle, M. B. Graeber, D. R. Edwards, and J. S. Friedland
Monocyte-Astrocyte Networks Regulate Matrix Metalloproteinase Gene Expression and Secretion in Central Nervous System Tuberculosis In Vitro and In Vivo
J. Immunol., January 15, 2007; 178(2): 1199 - 1207.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Sarkar, R. K. Nuttall, S. Liu, D. R. Edwards, and V. W. Yong
Tenascin-C Stimulates Glioma Cell Invasion through Matrix Metalloproteinase-12
Cancer Res., December 15, 2006; 66(24): 11771 - 11780.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
G. Eisele, J. Wischhusen, M. Mittelbronn, R. Meyermann, I. Waldhauer, A. Steinle, M. Weller, and M. A. Friese
TGF-{beta} and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells
Brain, September 1, 2006; 129(9): 2416 - 2425.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Chabottaux, N. E. Sounni, C. J. Pennington, W. R. English, F. van den Brule, S. Blacher, C. Gilles, C. Munaut, E. Maquoi, C. Lopez-Otin, et al.
Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.
Cancer Res., May 15, 2006; 66(10): 5165 - 5172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. T. G. Elkington, R. K. Nuttall, J. J. Boyle, C. M. O'Kane, D. E. Horncastle, D. R. Edwards, and J. S. Friedland
Mycobacterium tuberculosis, but Not Vaccine BCG, Specifically Upregulates Matrix Metalloproteinase-1
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1596 - 1604.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Zhang, S. Sarkar, and V.W. Yong
The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase
Carcinogenesis, December 1, 2005; 26(12): 2069 - 2077.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. X. Pedersen, C. J. Pennington, K. Almholt, I. J. Christensen, B. S. Nielsen, D. R. Edwards, J. Romer, K. Dano, and M. Johnsen
Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas
Carcinogenesis, July 1, 2005; 26(7): 1233 - 1240.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Fabre-Lafay, S. Garrido-Urbani, N. Reymond, A. Goncalves, P. Dubreuil, and M. Lopez
Nectin-4, a New Serological Breast Cancer Marker, Is a Substrate for Tumor Necrosis Factor-{alpha}-converting Enzyme (TACE)/ADAM-17
J. Biol. Chem., May 20, 2005; 280(20): 19543 - 19550.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. V. Rozanov, A. Y. Savinov, V. S. Golubkov, T. I. Postnova, A. Remacle, S. Tomlinson, and A. Y. Strongin
Cellular Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Cleaves C3b, an Essential Component of the Complement System
J. Biol. Chem., November 5, 2004; 279(45): 46551 - 46557.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Toft-Hansen, R. K. Nuttall, D. R. Edwards, and T. Owens
Key Metalloproteinases Are Expressed by Specific Cell Types in Experimental Autoimmune Encephalomyelitis
J. Immunol., October 15, 2004; 173(8): 5209 - 5218.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. E. Sounni, C. Roghi, V. Chabottaux, M. Janssen, C. Munaut, E. Maquoi, B. G. Galvez, C. Gilles, F. Frankenne, G. Murphy, et al.
Up-regulation of Vascular Endothelial Growth Factor-A by Active Membrane-type 1 Matrix Metalloproteinase through Activation of Src-Tyrosine Kinases
J. Biol. Chem., April 2, 2004; 279(14): 13564 - 13574.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zhao, M. M. Bernardo, P. Osenkowski, A. Sohail, D. Pei, H. Nagase, M. Kashiwagi, P. D. Soloway, Y. A. DeClerck, and R. Fridman
Differential Inhibition of Membrane Type 3 (MT3)-Matrix Metalloproteinase (MMP) and MT1-MMP by Tissue Inhibitor of Metalloproteinase (TIMP)-2 and TIMP-3 Regulates Pro-MMP-2 Activation
J. Biol. Chem., March 5, 2004; 279(10): 8592 - 8601.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Bar-Or, R. K. Nuttall, M. Duddy, A. Alter, H. J. Kim, I. Ifergan, C. J. Pennington, P. Bourgoin, D. R. Edwards, and V. W. Yong
Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis
Brain, December 1, 2003; 126(12): 2738 - 2749.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. E. A. Wells, T. K. Rice, R. K. Nuttall, D. R. Edwards, H. Zekki, S. Rivest, and V. W. Yong
An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice
J. Neurosci., November 5, 2003; 23(31): 10107 - 10115.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.